Valuation: Adocia

Market Cap 75.45M 86.29M 69.6M 63.98M 121M 8.3B 123M 831M 326M 4.06B 324M 317M 13.99B P/E 2026 *
15.6x
P/E 2027 * 7.74x
Enterprise Value 45.6M 52.16M 42.07M 38.67M 73.27M 5.02B 74.52M 502M 197M 2.45B 196M 192M 8.46B EV / Sales 2026 *
3.65x
EV / Sales 2027 * 3.27x
Free-Float
90.95%
Yield 2026 *
-
Yield 2027 * -
1 day+1.66%
1 week+2.78%
Current month-5.31%
1 month-10.91%
3 months-16.74%
6 months-35.84%
Current year-41.49%
1 week 3.61
Extreme 3.61
4.01
1 month 3.61
Extreme 3.61
4.71
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Date Insider Type Main position Quantity % Market Cap.
27/02/25Buy

Founder

109,170 0.6972%
06/04/24Buy

Founder

15,576 0.1105%
06/04/24Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+1.66%+2.78%-0.63%+0.90% 86.33M
-1.39%-6.15%+56.05%+71.53% 54.49B
+3.13%+11.16%+67.30%+94.35% 55.93B
-0.90%-6.29%+6.15%+427.54% 23.87B
-0.42%-3.36%-18.31%-15.69% 22.86B
+3.51%+7.50%+47.81%-3.33% 20B
+1.94%+0.21%+39.31%-29.41% 17.48B
+10.00%-2.06%+210.10%+370.99% 15.39B
+7.69%+4.38%+56.51%+712.88% 15.19B
-0.07%-0.61%+26.57%+190.59% 14.02B
Average +2.50%+0.02%+49.09%+182.04% 23.93B
Weighted average by Cap. +1.84%+0.47%+52.88%+157.33%

Financials

2026 *2027 *
Net sales 12.5M 14.3M 11.53M 10.6M 20.08M 1.38B 20.43M 138M 54.01M 672M 53.69M 52.51M 2.32B 32.26M 36.89M 29.75M 27.35M 51.83M 3.55B 52.71M 355M 139M 1.74B 139M 136M 5.98B
Net income -518K -592K -478K -439K -832K -56.99M -846K -5.7M -2.24M -27.86M -2.22M -2.18M -96.01M -47.3M -54.11M -43.64M -40.11M -76.01M -5.21B -77.31M -521M -204M -2.54B -203M -199M -8.77B
Net Debt -29.84M -34.13M -27.53M -25.31M -47.95M -3.28B -48.77M -329M -129M -1.61B -128M -125M -5.53B 30.18M 34.51M 27.84M 25.59M 48.49M 3.32B 49.31M 332M 130M 1.62B 130M 127M 5.59B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
15/07/26 3.920 +1.66% 57,642
14/07/26 €3.856 +3.16% 117,291
13/07/26 €3.738 -0.05% 66,472
10/07/26 €3.740 -4.83% 221,599
09/07/26 €3.930 +3.04% 105,717
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.856EUR
Average target price
10.70EUR
Spread / Average Target
+177.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock